HomeCompaniesProfile

Humane Genomics

A platform to make artificial viruses as cancer therapeutics. 


Company Size

1 - 5 employees

Year Founded

2019


About Humane Genomics

Humane Genomics has developed a platform to engineer cancer killing viruses. We have taken a first principles approach to design and make oncolytic viral therapies. Using a highly lytic RNA virus engineered with "2 factor authentication" (using selective infection and selective replication) they have an on-target to off-target kill ratio > 1000. We are working on our first indication, pediatric liver cancer (hepatoblastoma), with our partners at Texas Children's Hospital, who are world leading experts. We have in vivo (mouse) data showing safety and currently developing efficacy data and are showing 50% reduction in tumor volume.

Founders & Key People

Chad Moles

Chad Moles

Founder, Humane Genomics

Peter Weijmarshausen

Peter Weijmarshausen

Founder, Humane Genomics

Share This Profile

More Companies

Sirius A

At SiriusA, we make accessibility to capital market easy for all companies.

Wyndly

Life's better without allergies

One Codex

Data platform for metagenomics and the microbiome.

Nextera Robotics

AI-native Robotics

Sled

Chat with your Data Warehouse

Hilos

Close and activate your customers on WhatsApp

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.